The efficacy and associated bleeding complications of recombinant antithrombin supplementation among intensive care unit patients
The aim of this study was to evaluate the efficacy and complications of recombinant antithrombin (rAT) supplementation for adult patients with disseminated intravascular coagulation (DIC) compared with conventional plasma derived AT (pAT) treatment in the intensive care unit.
Gespeichert in:
| Autor*in: |
Koami, Hiroyuki [verfasserIn] |
|---|
| Format: |
E-Artikel |
|---|---|
| Sprache: |
Englisch |
| Erschienen: |
2017 |
|---|
| Umfang: |
6 |
|---|
| Übergeordnetes Werk: |
Enthalten in: DNA-PKcs Expression Predicts Response to Radiotherapy in Prostate Cancer - 2012, vascular obstruction, hemorrhage and hemostasis, Amsterdam [u.a.] |
|---|---|
| Übergeordnetes Werk: |
volume:157 ; year:2017 ; pages:84-89 ; extent:6 |
| Links: |
|---|
| DOI / URN: |
10.1016/j.thromres.2017.06.035 |
|---|
| Katalog-ID: |
ELV036235466 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | ELV036235466 | ||
| 003 | DE-627 | ||
| 005 | 20230624025753.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 180603s2017 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.thromres.2017.06.035 |2 doi | |
| 028 | 5 | 2 | |a GBVA2017022000030.pica |
| 035 | |a (DE-627)ELV036235466 | ||
| 035 | |a (ELSEVIER)S0049-3848(17)30399-7 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | |a 610 | |
| 082 | 0 | 4 | |a 610 |q DE-600 |
| 082 | 0 | 4 | |a 610 |q VZ |
| 082 | 0 | 4 | |a 610 |q VZ |
| 084 | |a 44.40 |2 bkl | ||
| 100 | 1 | |a Koami, Hiroyuki |e verfasserin |4 aut | |
| 245 | 1 | 4 | |a The efficacy and associated bleeding complications of recombinant antithrombin supplementation among intensive care unit patients |
| 264 | 1 | |c 2017 | |
| 300 | |a 6 | ||
| 336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
| 337 | |a nicht spezifiziert |b z |2 rdamedia | ||
| 338 | |a nicht spezifiziert |b zu |2 rdacarrier | ||
| 520 | |a The aim of this study was to evaluate the efficacy and complications of recombinant antithrombin (rAT) supplementation for adult patients with disseminated intravascular coagulation (DIC) compared with conventional plasma derived AT (pAT) treatment in the intensive care unit. | ||
| 700 | 1 | |a Sakamoto, Yuichiro |4 oth | |
| 700 | 1 | |a Sakurai, Ryota |4 oth | |
| 700 | 1 | |a Ohta, Miho |4 oth | |
| 700 | 1 | |a Imahase, Hisashi |4 oth | |
| 700 | 1 | |a Yahata, Mayuko |4 oth | |
| 700 | 1 | |a Umeka, Mitsuru |4 oth | |
| 700 | 1 | |a Miike, Toru |4 oth | |
| 700 | 1 | |a Nagashima, Futoshi |4 oth | |
| 700 | 1 | |a Iwamura, Takashi |4 oth | |
| 700 | 1 | |a Yamada, Kosuke Chris |4 oth | |
| 700 | 1 | |a Inoue, Satoshi |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |n Elsevier Science |t DNA-PKcs Expression Predicts Response to Radiotherapy in Prostate Cancer |d 2012 |d vascular obstruction, hemorrhage and hemostasis |g Amsterdam [u.a.] |w (DE-627)ELV011105356 |
| 773 | 1 | 8 | |g volume:157 |g year:2017 |g pages:84-89 |g extent:6 |
| 856 | 4 | 0 | |u https://doi.org/10.1016/j.thromres.2017.06.035 |3 Volltext |
| 912 | |a GBV_USEFLAG_U | ||
| 912 | |a GBV_ELV | ||
| 912 | |a SYSFLAG_U | ||
| 912 | |a SSG-OLC-PHA | ||
| 912 | |a SSG-OPC-PHA | ||
| 912 | |a GBV_ILN_24 | ||
| 912 | |a GBV_ILN_40 | ||
| 936 | b | k | |a 44.40 |j Pharmazie |j Pharmazeutika |q VZ |
| 951 | |a AR | ||
| 952 | |d 157 |j 2017 |h 84-89 |g 6 | ||
| 953 | |2 045F |a 610 | ||
| author_variant |
h k hk |
|---|---|
| matchkey_str |
koamihiroyukisakamotoyuichirosakurairyot:2017----:hefccadsoitdleigopiainorcmiatnihobnupeetto |
| hierarchy_sort_str |
2017 |
| bklnumber |
44.40 |
| publishDate |
2017 |
| allfields |
10.1016/j.thromres.2017.06.035 doi GBVA2017022000030.pica (DE-627)ELV036235466 (ELSEVIER)S0049-3848(17)30399-7 DE-627 ger DE-627 rakwb eng 610 610 DE-600 610 VZ 610 VZ 44.40 bkl Koami, Hiroyuki verfasserin aut The efficacy and associated bleeding complications of recombinant antithrombin supplementation among intensive care unit patients 2017 6 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier The aim of this study was to evaluate the efficacy and complications of recombinant antithrombin (rAT) supplementation for adult patients with disseminated intravascular coagulation (DIC) compared with conventional plasma derived AT (pAT) treatment in the intensive care unit. Sakamoto, Yuichiro oth Sakurai, Ryota oth Ohta, Miho oth Imahase, Hisashi oth Yahata, Mayuko oth Umeka, Mitsuru oth Miike, Toru oth Nagashima, Futoshi oth Iwamura, Takashi oth Yamada, Kosuke Chris oth Inoue, Satoshi oth Enthalten in Elsevier Science DNA-PKcs Expression Predicts Response to Radiotherapy in Prostate Cancer 2012 vascular obstruction, hemorrhage and hemostasis Amsterdam [u.a.] (DE-627)ELV011105356 volume:157 year:2017 pages:84-89 extent:6 https://doi.org/10.1016/j.thromres.2017.06.035 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA SSG-OPC-PHA GBV_ILN_24 GBV_ILN_40 44.40 Pharmazie Pharmazeutika VZ AR 157 2017 84-89 6 045F 610 |
| spelling |
10.1016/j.thromres.2017.06.035 doi GBVA2017022000030.pica (DE-627)ELV036235466 (ELSEVIER)S0049-3848(17)30399-7 DE-627 ger DE-627 rakwb eng 610 610 DE-600 610 VZ 610 VZ 44.40 bkl Koami, Hiroyuki verfasserin aut The efficacy and associated bleeding complications of recombinant antithrombin supplementation among intensive care unit patients 2017 6 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier The aim of this study was to evaluate the efficacy and complications of recombinant antithrombin (rAT) supplementation for adult patients with disseminated intravascular coagulation (DIC) compared with conventional plasma derived AT (pAT) treatment in the intensive care unit. Sakamoto, Yuichiro oth Sakurai, Ryota oth Ohta, Miho oth Imahase, Hisashi oth Yahata, Mayuko oth Umeka, Mitsuru oth Miike, Toru oth Nagashima, Futoshi oth Iwamura, Takashi oth Yamada, Kosuke Chris oth Inoue, Satoshi oth Enthalten in Elsevier Science DNA-PKcs Expression Predicts Response to Radiotherapy in Prostate Cancer 2012 vascular obstruction, hemorrhage and hemostasis Amsterdam [u.a.] (DE-627)ELV011105356 volume:157 year:2017 pages:84-89 extent:6 https://doi.org/10.1016/j.thromres.2017.06.035 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA SSG-OPC-PHA GBV_ILN_24 GBV_ILN_40 44.40 Pharmazie Pharmazeutika VZ AR 157 2017 84-89 6 045F 610 |
| allfields_unstemmed |
10.1016/j.thromres.2017.06.035 doi GBVA2017022000030.pica (DE-627)ELV036235466 (ELSEVIER)S0049-3848(17)30399-7 DE-627 ger DE-627 rakwb eng 610 610 DE-600 610 VZ 610 VZ 44.40 bkl Koami, Hiroyuki verfasserin aut The efficacy and associated bleeding complications of recombinant antithrombin supplementation among intensive care unit patients 2017 6 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier The aim of this study was to evaluate the efficacy and complications of recombinant antithrombin (rAT) supplementation for adult patients with disseminated intravascular coagulation (DIC) compared with conventional plasma derived AT (pAT) treatment in the intensive care unit. Sakamoto, Yuichiro oth Sakurai, Ryota oth Ohta, Miho oth Imahase, Hisashi oth Yahata, Mayuko oth Umeka, Mitsuru oth Miike, Toru oth Nagashima, Futoshi oth Iwamura, Takashi oth Yamada, Kosuke Chris oth Inoue, Satoshi oth Enthalten in Elsevier Science DNA-PKcs Expression Predicts Response to Radiotherapy in Prostate Cancer 2012 vascular obstruction, hemorrhage and hemostasis Amsterdam [u.a.] (DE-627)ELV011105356 volume:157 year:2017 pages:84-89 extent:6 https://doi.org/10.1016/j.thromres.2017.06.035 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA SSG-OPC-PHA GBV_ILN_24 GBV_ILN_40 44.40 Pharmazie Pharmazeutika VZ AR 157 2017 84-89 6 045F 610 |
| allfieldsGer |
10.1016/j.thromres.2017.06.035 doi GBVA2017022000030.pica (DE-627)ELV036235466 (ELSEVIER)S0049-3848(17)30399-7 DE-627 ger DE-627 rakwb eng 610 610 DE-600 610 VZ 610 VZ 44.40 bkl Koami, Hiroyuki verfasserin aut The efficacy and associated bleeding complications of recombinant antithrombin supplementation among intensive care unit patients 2017 6 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier The aim of this study was to evaluate the efficacy and complications of recombinant antithrombin (rAT) supplementation for adult patients with disseminated intravascular coagulation (DIC) compared with conventional plasma derived AT (pAT) treatment in the intensive care unit. Sakamoto, Yuichiro oth Sakurai, Ryota oth Ohta, Miho oth Imahase, Hisashi oth Yahata, Mayuko oth Umeka, Mitsuru oth Miike, Toru oth Nagashima, Futoshi oth Iwamura, Takashi oth Yamada, Kosuke Chris oth Inoue, Satoshi oth Enthalten in Elsevier Science DNA-PKcs Expression Predicts Response to Radiotherapy in Prostate Cancer 2012 vascular obstruction, hemorrhage and hemostasis Amsterdam [u.a.] (DE-627)ELV011105356 volume:157 year:2017 pages:84-89 extent:6 https://doi.org/10.1016/j.thromres.2017.06.035 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA SSG-OPC-PHA GBV_ILN_24 GBV_ILN_40 44.40 Pharmazie Pharmazeutika VZ AR 157 2017 84-89 6 045F 610 |
| allfieldsSound |
10.1016/j.thromres.2017.06.035 doi GBVA2017022000030.pica (DE-627)ELV036235466 (ELSEVIER)S0049-3848(17)30399-7 DE-627 ger DE-627 rakwb eng 610 610 DE-600 610 VZ 610 VZ 44.40 bkl Koami, Hiroyuki verfasserin aut The efficacy and associated bleeding complications of recombinant antithrombin supplementation among intensive care unit patients 2017 6 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier The aim of this study was to evaluate the efficacy and complications of recombinant antithrombin (rAT) supplementation for adult patients with disseminated intravascular coagulation (DIC) compared with conventional plasma derived AT (pAT) treatment in the intensive care unit. Sakamoto, Yuichiro oth Sakurai, Ryota oth Ohta, Miho oth Imahase, Hisashi oth Yahata, Mayuko oth Umeka, Mitsuru oth Miike, Toru oth Nagashima, Futoshi oth Iwamura, Takashi oth Yamada, Kosuke Chris oth Inoue, Satoshi oth Enthalten in Elsevier Science DNA-PKcs Expression Predicts Response to Radiotherapy in Prostate Cancer 2012 vascular obstruction, hemorrhage and hemostasis Amsterdam [u.a.] (DE-627)ELV011105356 volume:157 year:2017 pages:84-89 extent:6 https://doi.org/10.1016/j.thromres.2017.06.035 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA SSG-OPC-PHA GBV_ILN_24 GBV_ILN_40 44.40 Pharmazie Pharmazeutika VZ AR 157 2017 84-89 6 045F 610 |
| language |
English |
| source |
Enthalten in DNA-PKcs Expression Predicts Response to Radiotherapy in Prostate Cancer Amsterdam [u.a.] volume:157 year:2017 pages:84-89 extent:6 |
| sourceStr |
Enthalten in DNA-PKcs Expression Predicts Response to Radiotherapy in Prostate Cancer Amsterdam [u.a.] volume:157 year:2017 pages:84-89 extent:6 |
| format_phy_str_mv |
Article |
| bklname |
Pharmazie Pharmazeutika |
| institution |
findex.gbv.de |
| dewey-raw |
610 |
| isfreeaccess_bool |
false |
| container_title |
DNA-PKcs Expression Predicts Response to Radiotherapy in Prostate Cancer |
| authorswithroles_txt_mv |
Koami, Hiroyuki @@aut@@ Sakamoto, Yuichiro @@oth@@ Sakurai, Ryota @@oth@@ Ohta, Miho @@oth@@ Imahase, Hisashi @@oth@@ Yahata, Mayuko @@oth@@ Umeka, Mitsuru @@oth@@ Miike, Toru @@oth@@ Nagashima, Futoshi @@oth@@ Iwamura, Takashi @@oth@@ Yamada, Kosuke Chris @@oth@@ Inoue, Satoshi @@oth@@ |
| publishDateDaySort_date |
2017-01-01T00:00:00Z |
| hierarchy_top_id |
ELV011105356 |
| dewey-sort |
3610 |
| id |
ELV036235466 |
| language_de |
englisch |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV036235466</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230624025753.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180603s2017 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.thromres.2017.06.035</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBVA2017022000030.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV036235466</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0049-3848(17)30399-7</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.40</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Koami, Hiroyuki</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="4"><subfield code="a">The efficacy and associated bleeding complications of recombinant antithrombin supplementation among intensive care unit patients</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2017</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">6</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">The aim of this study was to evaluate the efficacy and complications of recombinant antithrombin (rAT) supplementation for adult patients with disseminated intravascular coagulation (DIC) compared with conventional plasma derived AT (pAT) treatment in the intensive care unit.</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Sakamoto, Yuichiro</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Sakurai, Ryota</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Ohta, Miho</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Imahase, Hisashi</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Yahata, Mayuko</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Umeka, Mitsuru</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Miike, Toru</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Nagashima, Futoshi</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Iwamura, Takashi</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Yamada, Kosuke Chris</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Inoue, Satoshi</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier Science</subfield><subfield code="t">DNA-PKcs Expression Predicts Response to Radiotherapy in Prostate Cancer</subfield><subfield code="d">2012</subfield><subfield code="d">vascular obstruction, hemorrhage and hemostasis</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV011105356</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:157</subfield><subfield code="g">year:2017</subfield><subfield code="g">pages:84-89</subfield><subfield code="g">extent:6</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.thromres.2017.06.035</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OPC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_24</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_40</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.40</subfield><subfield code="j">Pharmazie</subfield><subfield code="j">Pharmazeutika</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">157</subfield><subfield code="j">2017</subfield><subfield code="h">84-89</subfield><subfield code="g">6</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">610</subfield></datafield></record></collection>
|
| author |
Koami, Hiroyuki |
| spellingShingle |
Koami, Hiroyuki ddc 610 bkl 44.40 The efficacy and associated bleeding complications of recombinant antithrombin supplementation among intensive care unit patients |
| authorStr |
Koami, Hiroyuki |
| ppnlink_with_tag_str_mv |
@@773@@(DE-627)ELV011105356 |
| format |
electronic Article |
| dewey-ones |
610 - Medicine & health |
| delete_txt_mv |
keep |
| author_role |
aut |
| collection |
elsevier |
| remote_str |
true |
| illustrated |
Not Illustrated |
| topic_title |
610 610 DE-600 610 VZ 44.40 bkl The efficacy and associated bleeding complications of recombinant antithrombin supplementation among intensive care unit patients |
| topic |
ddc 610 bkl 44.40 |
| topic_unstemmed |
ddc 610 bkl 44.40 |
| topic_browse |
ddc 610 bkl 44.40 |
| format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
| format_main_str_mv |
Text Zeitschrift/Artikel |
| carriertype_str_mv |
zu |
| author2_variant |
y s ys r s rs m o mo h i hi m y my m u mu t m tm f n fn t i ti k c y kc kcy s i si |
| hierarchy_parent_title |
DNA-PKcs Expression Predicts Response to Radiotherapy in Prostate Cancer |
| hierarchy_parent_id |
ELV011105356 |
| dewey-tens |
610 - Medicine & health |
| hierarchy_top_title |
DNA-PKcs Expression Predicts Response to Radiotherapy in Prostate Cancer |
| isfreeaccess_txt |
false |
| familylinks_str_mv |
(DE-627)ELV011105356 |
| title |
The efficacy and associated bleeding complications of recombinant antithrombin supplementation among intensive care unit patients |
| ctrlnum |
(DE-627)ELV036235466 (ELSEVIER)S0049-3848(17)30399-7 |
| title_full |
The efficacy and associated bleeding complications of recombinant antithrombin supplementation among intensive care unit patients |
| author_sort |
Koami, Hiroyuki |
| journal |
DNA-PKcs Expression Predicts Response to Radiotherapy in Prostate Cancer |
| journalStr |
DNA-PKcs Expression Predicts Response to Radiotherapy in Prostate Cancer |
| lang_code |
eng |
| isOA_bool |
false |
| dewey-hundreds |
600 - Technology |
| recordtype |
marc |
| publishDateSort |
2017 |
| contenttype_str_mv |
zzz |
| container_start_page |
84 |
| author_browse |
Koami, Hiroyuki |
| container_volume |
157 |
| physical |
6 |
| class |
610 610 DE-600 610 VZ 44.40 bkl |
| format_se |
Elektronische Aufsätze |
| author-letter |
Koami, Hiroyuki |
| doi_str_mv |
10.1016/j.thromres.2017.06.035 |
| dewey-full |
610 |
| title_sort |
efficacy and associated bleeding complications of recombinant antithrombin supplementation among intensive care unit patients |
| title_auth |
The efficacy and associated bleeding complications of recombinant antithrombin supplementation among intensive care unit patients |
| abstract |
The aim of this study was to evaluate the efficacy and complications of recombinant antithrombin (rAT) supplementation for adult patients with disseminated intravascular coagulation (DIC) compared with conventional plasma derived AT (pAT) treatment in the intensive care unit. |
| abstractGer |
The aim of this study was to evaluate the efficacy and complications of recombinant antithrombin (rAT) supplementation for adult patients with disseminated intravascular coagulation (DIC) compared with conventional plasma derived AT (pAT) treatment in the intensive care unit. |
| abstract_unstemmed |
The aim of this study was to evaluate the efficacy and complications of recombinant antithrombin (rAT) supplementation for adult patients with disseminated intravascular coagulation (DIC) compared with conventional plasma derived AT (pAT) treatment in the intensive care unit. |
| collection_details |
GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA SSG-OPC-PHA GBV_ILN_24 GBV_ILN_40 |
| title_short |
The efficacy and associated bleeding complications of recombinant antithrombin supplementation among intensive care unit patients |
| url |
https://doi.org/10.1016/j.thromres.2017.06.035 |
| remote_bool |
true |
| author2 |
Sakamoto, Yuichiro Sakurai, Ryota Ohta, Miho Imahase, Hisashi Yahata, Mayuko Umeka, Mitsuru Miike, Toru Nagashima, Futoshi Iwamura, Takashi Yamada, Kosuke Chris Inoue, Satoshi |
| author2Str |
Sakamoto, Yuichiro Sakurai, Ryota Ohta, Miho Imahase, Hisashi Yahata, Mayuko Umeka, Mitsuru Miike, Toru Nagashima, Futoshi Iwamura, Takashi Yamada, Kosuke Chris Inoue, Satoshi |
| ppnlink |
ELV011105356 |
| mediatype_str_mv |
z |
| isOA_txt |
false |
| hochschulschrift_bool |
false |
| author2_role |
oth oth oth oth oth oth oth oth oth oth oth |
| doi_str |
10.1016/j.thromres.2017.06.035 |
| up_date |
2024-07-06T19:39:52.778Z |
| _version_ |
1803859832631984128 |
| fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV036235466</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230624025753.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180603s2017 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.thromres.2017.06.035</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBVA2017022000030.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV036235466</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0049-3848(17)30399-7</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.40</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Koami, Hiroyuki</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="4"><subfield code="a">The efficacy and associated bleeding complications of recombinant antithrombin supplementation among intensive care unit patients</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2017</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">6</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">The aim of this study was to evaluate the efficacy and complications of recombinant antithrombin (rAT) supplementation for adult patients with disseminated intravascular coagulation (DIC) compared with conventional plasma derived AT (pAT) treatment in the intensive care unit.</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Sakamoto, Yuichiro</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Sakurai, Ryota</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Ohta, Miho</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Imahase, Hisashi</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Yahata, Mayuko</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Umeka, Mitsuru</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Miike, Toru</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Nagashima, Futoshi</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Iwamura, Takashi</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Yamada, Kosuke Chris</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Inoue, Satoshi</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier Science</subfield><subfield code="t">DNA-PKcs Expression Predicts Response to Radiotherapy in Prostate Cancer</subfield><subfield code="d">2012</subfield><subfield code="d">vascular obstruction, hemorrhage and hemostasis</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV011105356</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:157</subfield><subfield code="g">year:2017</subfield><subfield code="g">pages:84-89</subfield><subfield code="g">extent:6</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.thromres.2017.06.035</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OPC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_24</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_40</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.40</subfield><subfield code="j">Pharmazie</subfield><subfield code="j">Pharmazeutika</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">157</subfield><subfield code="j">2017</subfield><subfield code="h">84-89</subfield><subfield code="g">6</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">610</subfield></datafield></record></collection>
|
| score |
7.4026117 |